Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities (Q51762349)

11 April 2018

http://europepmc.org/abstract/MED/29548901

title

Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities (English)

1 reference

11 April 2018

http://europepmc.org/abstract/MED/29548901

author

Gabriele Giacomo Schiattarella

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29548901 AND SRC:MED&resulttype=core&format=json

7 June 2020

Rosalinda Madonna

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29548901 AND SRC:MED&resulttype=core&format=json

7 June 2020

Rainer Schulz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29548901 AND SRC:MED&resulttype=core&format=json

7 June 2020

3

Sophie Van Linthout

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29548901 AND SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Thomas Thum

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29548901 AND SRC:MED&resulttype=core&format=json

7 June 2020

Peter Ferdinandy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29548901 AND SRC:MED&resulttype=core&format=json

7 June 2020

Cinzia Perrino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29548901 AND SRC:MED&resulttype=core&format=json

7 June 2020

publication date

13 March 2018

1 reference

11 April 2018

http://europepmc.org/abstract/MED/29548901

published in

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29548901 AND SRC:MED&resulttype=core&format=json

Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Endothelial plasticity drives arterial remodeling within the endocardium after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetics: a landscape takes shape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Long Noncoding RNAs in Pathological Cardiac Remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetic switch at atp2a2 and myh7 gene promoters in pressure overload-induced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Cardiovascular effects of histone deacetylase inhibitors epigenetic therapies: Systematic review of 62 studies and new hypotheses for future research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Chromosome territories, nuclear architecture and gene regulation in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Human DNA methylomes at base resolution show widespread epigenomic differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

CpG-rich islands and the function of DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

TET-mediated active DNA demethylation: mechanism, function and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Readers, writers, and erasers: chromatin as the whiteboard of heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Histone demethylation by a family of JmjC domain-containing proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Noncoding RNAs and gene silencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Biogenesis and regulation of cardiovascular microRNAs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

A large shRNA library approach identifies lncRNA Ntep as an essential regulator of cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

lincRNAs: genomics, evolution, and mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

MicroRNAs in Cardiovascular Disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetics and cardiovascular development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Histone deacetylase 7 controls endothelial cell growth through modulation of beta-catenin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetic Modifications in Essential Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Differential expression and DNA methylation of angiotensin type 1A receptors in vascular tissues during genetic hypertension development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The emerging role of non-coding RNA in essential hypertension and blood pressure regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Recent insights into the cellular biology of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

DNA methylation map of human atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetics of Atherosclerosis: Emerging Mechanisms and Methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Histone and DNA methylation-mediated epigenetic downregulation of endothelial Kruppel-like factor 2 by low-density lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Prenatal exposure to apoE deficiency and postnatal hypercholesterolemia are associated with altered cell-specific lysine methyltransferase and histone methylation patterns in the vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

A common variant on chromosome 9p21 affects the risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Apolipoprotein A-I gene transfer exerts immunomodulatory effects and reduces vascular inflammation and fibrosis in ob/ob mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Regulation of the apolipoprotein gene cluster by a long noncoding RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Endothelial microRNAs and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

MicroRNA-34a regulation of endothelial senescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

High-density lipoproteins reduce endothelial-to-mesenchymal transition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Hypoxia-induced endothelial-mesenchymal transition is associated with RASAL1 promoter hypermethylation in human coronary endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Histone deacetylase 3 unconventional splicing mediates endothelial-to-mesenchymal transition through transforming growth factor β2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetics in vascular disease - therapeutic potential of new agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The Yin-Yang Dynamics of DNA Methylation Is the Key Regulator for Smooth Muscle Cell Phenotype Switch and Vascular Remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

MicroRNAs for Restenosis and Thrombosis After Vascular Injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epidemiology, classification, and modifiable risk factors of peripheral arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Physical activity in the prevention of peripheral artery disease in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetic adaptation to regular exercise in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetics and Peripheral Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Therapeutic Potential of Modulating MicroRNA in Peripheral Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Trichostatin A enhances vascular repair by injected human endothelial progenitors through increasing the expression of TAL1-dependent genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The Role Matrix Metalloproteinases in the Production of Aortic Aneurysm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epidemiology and treatment of pulmonary arterial hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Molecular pathogenesis of pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The emerging role of epigenetics in pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Discerning functional hierarchies of microRNAs in pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Critical effects of epigenetic regulation in pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Methylation Analysis of the BMPR2 Gene Promoter Region in Patients With Pulmonary Arterial Hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Functional polymorphism of lncRNA MALAT1 contributes to pulmonary arterial hypertension susceptibility in Chinese people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands together

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Repression of P66Shc Expression by SIRT1 Contributes to the Prevention of Hyperglycemia-Induced Endothelial Dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Sirt 1 activator inhibits the AGE-induced apoptosis and p53 acetylation in human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

AGEs Decreased SIRT3 Expression and SIRT3 Activation Protected AGEs-Induced EPCs' Dysfunction and Strengthened Anti-oxidant Capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Sirtuin-6 deficiency exacerbates diabetes-induced impairment of wound healing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Adverse Epigenetic Signatures by Histone Methyltransferase Set7 Contribute to Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

microRNAs in Early Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Polycomb repressive complex 2 regulates MiR-200b in retinal endothelial cells: potential relevance in diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Effects of aging on angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The epigenetic landscape of age-related diseases: the geroscience perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Decline in genomic DNA methylation through aging in a cohort of elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Oxidative stress and epigenetic regulation in ageing and age-related diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

The role of sirtuins in aging and age-related diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

SIRT1 controls endothelial angiogenic functions during vascular growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Visfatin attenuates the ox-LDL-induced senescence of endothelial progenitor cells by upregulating SIRT1 expression through the PI3K/Akt/ERK pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetics of aging and aging-related disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

7 January 2021

The hallmarks of aging

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Enhanced angiogenic and cardiomyocyte differentiation capacity of epigenetically reprogrammed mouse and human endothelial progenitor cells augments their efficacy for ischemic myocardial repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

MicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Insulin-like growth factor 1 receptor signaling induced by supraphysiological doses of IGF-1 in human peripheral blood lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Screening of circulating microRNA biomarkers for prevalence of abdominal aortic aneurysm and aneurysm growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Targeting the cancer epigenome for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Gene body methylation can alter gene expression and is a therapeutic target in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Inhibiting DNA Methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Cocoa Consumption Alters the Global DNA Methylation of Peripheral Leukocytes in Humans with Cardiovascular Disease Risk Factors: A Randomized Controlled Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

Epigenetic changes induced by curcumin and other natural compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2018.02.009

10.1016/J.VPH.2018.02.009

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29548901 AND SRC:MED&resulttype=core&format=json

7 June 2020

1 reference